Garcia Hamilton & Associates’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-3,567
Closed -$305K 22
2017
Q3
$305K Sell
3,567
-4,150
-54% -$340K 0.79% 34
2017
Q2
$635K Sell
7,717
-5,048
-40% -$412K 0.88% 36
2017
Q1
$1.05M Sell
12,765
-10,452
-45% -$837K 0.93% 39
2016
Q4
$1.71M Sell
23,217
-990
-4% -$73.7K 0.99% 45
2016
Q3
$1.94M Buy
24,207
+8,249
+52% +$660K 1.14% 37
2016
Q2
$1.26M Sell
15,958
-589
-4% -$44.3K 0.76% 48
2016
Q1
$1.19M Buy
16,547
+173
+1% +$13.1K 0.69% 56
2015
Q4
$1.38M Buy
+16,374
New +$1.36M 0.81% 51

Other funds holding LLY

Garcia Hamilton & Associates's LLY Position: Q4 2017 in Review

Garcia Hamilton & Associates sold out of Eli Lilly (LLY) in Q4 2017, closing a stake of 3,567 shares — an estimated $305K sold.

Garcia Hamilton & Associates first reported a position in LLY in Q4 2015 and held it in 8 quarters. The position peaked at $1.94M in Q3 2016. 1,373 funds tracked by Wall St. Rank hold LLY as of Q4 2017.

  • Garcia Hamilton & Associates reported no remaining Eli Lilly position as of Q4 2017 after selling out during the quarter.
  • Garcia Hamilton & Associates sold 3,567 Eli Lilly shares in Q4 2017, an estimated $305K.
  • Garcia Hamilton & Associates first reported a position in Eli Lilly in Q4 2015 and held it in 8 quarters.
  • Garcia Hamilton & Associates's Eli Lilly position peaked at $1.94M in Q3 2016.
  • 1,373 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2017.

Based on Garcia Hamilton & Associates's 13F filing for Q4 2017, filed 19 Jan 2018.